Compare TTD & TFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TTD | TFX |
|---|---|---|
| Founded | 2009 | 1943 |
| Country | United States | United States |
| Employees | N/A | 15500 |
| Industry | Computer Software: Programming Data Processing | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.1B | 6.1B |
| IPO Year | 2016 | 1994 |
| Metric | TTD | TFX |
|---|---|---|
| Price | $15.75 | $154.84 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 35 | 12 |
| Target Price | $14.75 | ★ $168.09 |
| AVG Volume (30 Days) | ★ 16.9M | 761.3K |
| Earning Date | 11-09-2026 | 11-05-2026 |
| Dividend Yield | N/A | ★ 0.89% |
| EPS Growth | ★ 15.38 | N/A |
| EPS | 0.30 | ★ 23.58 |
| Revenue | ★ $2,896,284,000.00 | $1,992,713,000.00 |
| Revenue This Year | N/A | $13.62 |
| Revenue Next Year | N/A | $3.78 |
| P/E Ratio | $51.92 | ★ $6.51 |
| Revenue Growth | ★ 18.47 | N/A |
| 52 Week Low | $11.62 | $100.18 |
| 52 Week High | $41.91 | $156.75 |
| Indicator | TTD | TFX |
|---|---|---|
| Relative Strength Index (RSI) | 69.13 | 75.16 |
| Support Level | $11.92 | $120.85 |
| Resistance Level | $19.55 | N/A |
| Average True Range (ATR) | 0.79 | 4.68 |
| MACD | 0.38 | 1.15 |
| Stochastic Oscillator | 84.40 | 92.81 |
The Trade Desk provides a self-service platform that helps advertisers and ad agencies programmatically find and purchase digital ad inventory (display, video, audio, and social) on devices like computers, smartphones, and connected TVs. The firm's platform is referred to as a demand-side platform in the digital ad industry, and it generates revenue from fees based on a percentage of what its clients spend on advertising, referred to as a take rate.
Teleflex Inc is a provider of medical technology products focused on enhancing clinical benefits, improving patient and provider safety and reducing total procedural costs. It designs, develops, manufactures and supply medical devices used by hospitals and healthcare providers supporting high-acuity emergent procedures. The company has three reportable segments: Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). It derives maximum revenue from Americas. Its products includes: Anaesthesia, Emergency Medicine, Interventional Cardiology/Radiology, Interventional Urology - UroLift System, Surgery, Urology, and Vascular Access.